Аннотации:
100 children from 2 to 10 years of age including with bronchopulmonary pathology of viral-bacterial etiology
were examined for the purpose of studying the clinical efficacy and safety of the use of Inspiron. The main group of 50
children received Inspiron, control (50 people) – ambroxol. The efficacy and safety of the drug was assessed by the
dynamics of bronchial obstructive syndrome, cough, dyspnea, physical parameters of the respiratory system, tolerability and the presence of allergic reactions.
The carried out researches have shown high efficiency of the preparation «Inspiron». A pronounced bronchoobstructive, mucolytic, antitussive effect was revealed, and an easier withdrawal of sputum was recorded. In no case
are allergic reactions or laryngospasm recorded. There was a significant reduction in the stay of children in the hospital, which led to a reduction in the costs of the medical institution for treatment and examination.